Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Epidermodysplasia verruciformis
ADR ID BADD_A05129
ADR Hierarchy
11      Infections and infestations
11.05      Viral infectious disorders
11.05.07      Papilloma viral infections
11.05.07.004      Epidermodysplasia verruciformis
23      Skin and subcutaneous tissue disorders
23.11      Skin and subcutaneous tissue infections and infestations NEC
23.11.05      Skin and subcutaneous tissue viral infections
23.11.05.001      Epidermodysplasia verruciformis
Description An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales. [MeSH]
MedDRA Code 10052339
MeSH ID D004819
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Epidermodysplasia verruciformis | Lewandowsky-Lutz disease | Epidermodysplasia Verruciformis | Lewandowsky-Lutz Disease | Disease, Lewandowsky-Lutz | Lewandowsky Lutz Disease | Lutz-Lewandowsky Disease | Disease, Lutz-Lewandowsky | Lutz Lewandowsky Disease
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02308Trovafloxacin mesylate--
The 1th Page    1    Total 1 Pages